INCLUSION BODY MYOSITIS
Clinical trials for INCLUSION BODY MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new INCLUSION BODY MYOSITIS trials appear
Sign up with your email to follow new studies for INCLUSION BODY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ABC008 shows promise in slowing rare muscle disease
Disease control CompletedThis study tested a new drug, ABC008, in 272 adults with inclusion body myositis, a rare muscle-weakening disease. The goal was to see if the drug is safe and can help slow the disease's progression. Participants received either ABC008 or a placebo, and their muscle function was …
Matched conditions: INCLUSION BODY MYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Fat-Derived stem cells injected into muscles in new myositis trial
Symptom relief CompletedThis study tested whether stem cells taken from a person's own fat tissue are safe to inject into weakened muscles. Nine people with inclusion body myositis received injections in their forearm and thigh. The main goal was to check for side effects, not to measure improvement, th…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Military myositis mystery: could exposures be the trigger?
Knowledge-focused CompletedThis study investigated whether environmental exposures during military service increase the risk of developing myositis, a rare autoimmune disease that attacks muscles. Researchers compared 37 military personnel with and without myositis using questionnaires and blood samples. N…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC